{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:09:36Z","timestamp":1776204576978,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00432-018-02837-4","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:33:04Z","timestamp":1548329584000},"page":"695-707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Mistletoe in oncological treatment: a systematic review"],"prefix":"10.1007","volume":"145","author":[{"given":"M.","family":"Freuding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Keinki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Micke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Buentzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-568X","authenticated-orcid":false,"given":"Jutta","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"2837_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.remn.2016.07.005","volume":"36","author":"P Abreu","year":"2017","unstructured":"Abreu P, Sanchez R, Mut T, Balaguer D, Latorre I, Rodriguez H (2017) Homeopathic mistletoe adverse reaction mimics nodal involvement in 18F-FDG PET\/CT performed for evaluation of response to chemotherapy in lymphoma. Revista Espanola de Medicina Nuclear e Imagen Molecular 36:110\u2013112. \n                    https:\/\/doi.org\/10.1016\/j.remn.2016.07.005","journal-title":"Revista Espanola de Medicina Nuclear e Imagen Molecular"},{"key":"2837_CR2","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.ejca.2012.11.007","volume":"49","author":"G Bar-Sela","year":"2013","unstructured":"Bar-Sela G, Wollner M, Hammer L, Agbarya A, Dudnik E, Haim N (2013) Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study. Eur J Cancer 49:1058\u20131064","journal-title":"Eur J Cancer"},{"key":"2837_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/219402","author":"A Bussing","year":"2012","unstructured":"Bussing A, Raak C, Ostermann T (2012) Quality of life and related dimensions in cancer patients treated with mistletoe extract (iscador): a meta-analysis. Evid Based Complement Altern Med eCAM 2012. \n                    https:\/\/doi.org\/10.1155\/2012\/219402","journal-title":"Evid Based Complement Altern Med eCAM 2012"},{"key":"2837_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/108497803321269304","volume":"18","author":"M Cazacu","year":"2003","unstructured":"Cazacu M et al (2003) The influence of isorel on the advanced colorectal cancer. Cancer Biother Radiopharm 18:27\u201334","journal-title":"Cancer Biother Radiopharm"},{"key":"2837_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00432-014-1656-9","volume":"140","author":"AC Conrad","year":"2014","unstructured":"Conrad AC, Muenstedt K, Micke O, Prott FJ, Muecke R, Huebner J (2014) Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients. J Cancer Res Clin Oncol 140:1229\u20131237. \n                    https:\/\/doi.org\/10.1007\/s00432-014-1656-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"2837_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ejcdt.2015.12.017","volume":"65","author":"RM El-Kolaly","year":"2016","unstructured":"El-Kolaly RM, Abo-Elnasr M, El-Guindy D (2016) Outcome of pleurodesis using different agents in management of malignant pleural effusion Egyptian. J Chest Dis Tuberc 65:435\u2013440","journal-title":"J Chest Dis Tuberc"},{"key":"2837_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ijc.11386","volume":"107","author":"E Ernst","year":"2003","unstructured":"Ernst E, Schmidt K, Steuer-Vogt MK (2003) Mistletoe for cancer? A systematic review of randomised clinical trials. Int J Cancer 107:262\u2013267","journal-title":"Int J Cancer"},{"key":"2837_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3332\/ecancer.2014.424","volume":"8","author":"R Gaafar","year":"2014","unstructured":"Gaafar R, Abdel Rahman ARM, Aboulkasem F, El Bastawisy A (2014) Mistletoe preparation (Viscum Fraxini-2) as palliative treatment for malignant pleural effusion: a feasibility study with comparison to bleomycin. Ecancermedicalscience 8:424. \n                    https:\/\/doi.org\/10.3332\/ecancer.2014.424","journal-title":"Ecancermedicalscience"},{"key":"2837_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0022-5347(05)64834-3","volume":"168","author":"PJ Goebell","year":"2002","unstructured":"Goebell PJ, Otto T, Suhr J, Rubben H (2002) Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial. J Urol 168:72\u201375","journal-title":"J Urol"},{"key":"2837_CR10","first-page":"285","volume":"13","author":"R Grossarth-Maticek","year":"2006","unstructured":"Grossarth-Maticek R, Ziegler R (2006a) Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador). Forschende Komplementarmedizin (2006) 13:285\u2013292","journal-title":"Forschende Komplementarmedizin (2006)"},{"key":"2837_CR11","first-page":"485","volume":"11","author":"R Grossarth-Maticek","year":"2006","unstructured":"Grossarth-Maticek R, Ziegler R (2006b) Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis. Eur J Med Res 11:485\u2013495","journal-title":"Eur J Med Res"},{"key":"2837_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000285940","volume":"19","author":"R Grossarth-Maticek","year":"2007","unstructured":"Grossarth-Maticek R, Ziegler R (2007a) Efficacy and safety of the long-term treatment of melanoma with a mistletoe preparation (Iscador). Schweizerische Zeitschrift fur GanzheitsMedizin [German] 19:325\u2013332","journal-title":"Schweizerische Zeitschrift fur GanzheitsMedizin [German]"},{"key":"2837_CR13","first-page":"140","volume":"14","author":"R Grossarth-Maticek","year":"2007","unstructured":"Grossarth-Maticek R, Ziegler R (2007b) Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador) Forschende Komplementarmedizin (2006) 14:140\u2013147","journal-title":"Forschende Komplementarmedizin (2006)"},{"key":"2837_CR14","first-page":"665","volume":"57","author":"R Grossarth-Maticek","year":"2007","unstructured":"Grossarth-Maticek R, Ziegler R (2007c) Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador. Arzneimittelforschung 57:665\u2013678","journal-title":"Arzneimittelforschung"},{"key":"2837_CR15","first-page":"107","volume":"13","author":"R Grossarth-Maticek","year":"2008","unstructured":"Grossarth-Maticek R, Ziegler R (2008) Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador). Eur J Med Res 13:107\u2013120","journal-title":"Eur J Med Res"},{"key":"2837_CR16","first-page":"57","volume":"7","author":"R Grossarth-Maticek","year":"2001","unstructured":"Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R (2001) Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med 7:57\u201366 (68\u201372, 74\u201356 passim)","journal-title":"Altern Ther Health Med"},{"key":"2837_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1055\/s-2007-1024111","volume":"123","author":"W Hagenah","year":"1998","unstructured":"Hagenah W, Dorges I, Gafumbegete E, Wagner T (1998) Subcutaneous manifestations of a centrocytic non-Hodgkin lymphoma at the injection site of a mistletoe preparation. Deutsche medizinische Wochenschrift (1946) 123:1001\u20131004 \n                    https:\/\/doi.org\/10.1055\/s-2007-1024111","journal-title":"Deutsche medizinische Wochenschrift (1946)"},{"key":"2837_CR18","first-page":"419","volume":"48","author":"BM Heiny","year":"1997","unstructured":"Heiny BM, Albrecht V (1997) Complementary modes of therapy with mistletoe lectin-1. Medizinische Welt [German] 48:419\u2013423","journal-title":"Medizinische Welt [German]"},{"key":"2837_CR19","first-page":"583","volume":"18","author":"BM Heiny","year":"1998","unstructured":"Heiny BM, Albrecht V, Beuth J (1998) Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res 18:583\u2013586","journal-title":"Anticancer Res"},{"key":"2837_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1159\/000364897","volume":"37","author":"A Henf","year":"2014","unstructured":"Henf A, Wesselmann S, Huthmann D, Muenstedt K, Huebner J, On behalf of the Working Group P, Intergrative Oncology of the German Cancer Society J (2014) Complementary and alternative medicine in German Cancer Centers. Oncol Res Treat 37:390\u2013394. \n                    https:\/\/doi.org\/10.1159\/000364897","journal-title":"Oncol Res Treat"},{"key":"2837_CR21","unstructured":"Higgins JPT, Altman DG, Sterne JAC (2017) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (eds) Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane"},{"key":"2837_CR22","first-page":"CD003297","volume":"107","author":"MA Horneber","year":"2008","unstructured":"Horneber MA, Bueschel G, Huber R, Linde K, Rostock M (2008) Mistletoe therapy in oncology Cochrane Database of Syst Revi 107:CD003297","journal-title":"Cochrane Database of Syst Revi"},{"key":"2837_CR23","first-page":"36","volume":"30","author":"J Hubner","year":"2009","unstructured":"Hubner J, Phieler F (2009) Hypersensitivity reaction to oxaliplatinum recurrence during mistletoe therapy? Tumor Diagnostik Therapie [German] 30:36\u201339","journal-title":"Tumor Diagnostik Therapie [German]"},{"key":"2837_CR24","volume-title":"Komplement\u00e4re Onkologie - Supportive Ma\u00dfnahmen und evidenzbasierte Empfehlungen","author":"J Huebner","year":"2008","unstructured":"Huebner J (2008) Komplement\u00e4re Onkologie - Supportive Ma\u00dfnahmen und evidenzbasierte Empfehlungen. Schattauer, Stuttgart"},{"key":"2837_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0301-0546(01)79056-8","volume":"29","author":"N Hutt","year":"2001","unstructured":"Hutt N, Kopferschmitt-Kubler M, Cabalion J, Purohit A, Alt M, Pauli G (2001) Anaphylactic reactions after therapeutic injection of mistletoe (Viscum album L.). Allergologia et immunopathologia 29:201\u2013203","journal-title":"Allergologia et immunopathologia"},{"key":"2837_CR26","first-page":"103","volume":"12","author":"GS Kienle","year":"2007","unstructured":"Kienle GS, Kiene H (2007) Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res 12:103\u2013119","journal-title":"Eur J Med Res"},{"key":"2837_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/1534735410369673","volume":"9","author":"GS Kienle","year":"2010","unstructured":"Kienle GS, Kiene H (2010) Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther 9:142\u2013157","journal-title":"Integr Cancer Ther"},{"key":"2837_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1756-9966-28-79","volume":"28","author":"GS Kienle","year":"2009","unstructured":"Kienle GS, Glockmann A, Schink M, Kiene H (2009) Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Cancer Res 28:79","journal-title":"J Exp Clin Cancer Res"},{"key":"2837_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1472-6882-12-S1-P172","volume":"12","author":"KC Kim","year":"2012","unstructured":"Kim KC, Yook JH, Eisenbraun J, Kim BS, Huber R (2012) Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma\u2014a randomized, controlled pilot study. BMC Complement Altern Med 12:172","journal-title":"BMC Complement Altern Med"},{"key":"2837_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ejca.2003.07.004","volume":"40","author":"UR Kleeberg","year":"2004","unstructured":"Kleeberg UR et al (2004) Final results of the EORTC 18871\/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness> 3 mm) or regional lymph node metastasis. Eur J Cancer 40:390\u2013402","journal-title":"Eur J Cancer"},{"key":"2837_CR31","first-page":"Doc18","volume":"2","author":"A-M Lange-Lindberg","year":"2006","unstructured":"Lange-Lindberg A-M, Velasco Garrido M, Busse R (2006) Mistletoe treatments for minimising side effects of anticancer chemotherapy. GMS Health Technol Assess 2:Doc18","journal-title":"GMS Health Technol Assess"},{"key":"2837_CR32","first-page":"3799","volume":"16","author":"D Lenartz","year":"1996","unstructured":"Lenartz D, Stoffel B, Menzel J, Beuth J (1996) Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients. Anticancer Res 16:3799\u20133802","journal-title":"Anticancer Res"},{"key":"2837_CR33","first-page":"2073","volume":"20","author":"D Lenartz","year":"2000","unstructured":"Lenartz D, Dott U, Menzel J, Schierholz JM, Beuth J (2000) Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res 20:2073\u20132076","journal-title":"Anticancer Res"},{"key":"2837_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/210198","author":"A Longhi","year":"2014","unstructured":"Longhi A, Reif M, Mariani E, Ferrari S (2014) a randomized study on postrelapse disease-free survival with adjuvant mistletoe versus oral etoposide in osteosarcoma patients. Evid Based Complement Altern Med eCAM 2014. \n                    https:\/\/doi.org\/10.1155\/2014\/210198","journal-title":"Evid Based Complement Altern Med eCAM 2014"},{"key":"2837_CR35","first-page":"217","volume":"16","author":"J Melzer","year":"2009","unstructured":"Melzer J, Iten F, Hostanska K, Saller R (2009) Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forschende Komplementarmedizin (2006) 16:217\u2013226","journal-title":"Forschende Komplementarmedizin (2006)"},{"key":"2837_CR36","first-page":"277","volume":"8","author":"T Ostermann","year":"2012","unstructured":"Ostermann T, Bussing A (2012) Retrolective studies on the survival of cancer patients treated with mistletoe extracts: a meta-analysis. Explore J Sci Heal 8:277\u2013281","journal-title":"Explore J Sci Heal"},{"key":"2837_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/1471-2407-9-451","volume":"9","author":"T Ostermann","year":"2009","unstructured":"Ostermann T, Raak C, Bussing A (2009) Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. BMC Cancer 9:451","journal-title":"BMC Cancer"},{"key":"2837_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5414\/TEX01368","volume":"32","author":"IM Ott","year":"2015","unstructured":"Ott IM et al (2015) Attitude of oncology\/hematology nurses from German speaking countries towards complementary and alternative medicine. Trace Elem Electrolytes 32:74\u201380","journal-title":"Trace Elem Electrolytes"},{"key":"2837_CR39","first-page":"303","volume":"24","author":"BK Piao","year":"2004","unstructured":"Piao BK, Wang YX, Xie GR, Mansmann U, Matthes H, Beuth J, Lin HS (2004) Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res 24:303\u2013309","journal-title":"Anticancer Res"},{"key":"2837_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ctim.2004.09.006","volume":"12","author":"A Robinson","year":"2004","unstructured":"Robinson A, McGrail MR (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 12:90\u201398. \n                    https:\/\/doi.org\/10.1016\/j.ctim.2004.09.006","journal-title":"Complement Ther Med"},{"key":"2837_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1534735408323081","volume":"7","author":"GA Saxe","year":"2008","unstructured":"Saxe GA, Madlensky L, Kealey S, Wu DP, Freeman KL, Pierce JP (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the Women\u2019s Healthy Eating and Living Study. Integr Cancer Ther 7:122\u2013129. \n                    https:\/\/doi.org\/10.1177\/1534735408323081","journal-title":"Integr Cancer Ther"},{"key":"2837_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/s-2003-814594","volume":"35","author":"JM Schierholz","year":"2003","unstructured":"Schierholz JM et al (2003) Complementary cancer therapy with standardized mistletoe extracts. Results of a controlled prospective multicentric randomized clinical trial. [German] Deutsche Zeitschrift fur Onkologie 35:186\u2013194","journal-title":"[German] Deutsche Zeitschrift fur Onkologie"},{"key":"2837_CR43","first-page":"9","volume":"14","author":"M Schink","year":"2007","unstructured":"Schink M et al (2007) Mistletoe extract reduces the surgical suppression of natural killer cell activity in cancer patients. a randomized phase III trial. Forschende Komplementarmedizin (2006) 14:9\u201317","journal-title":"Forschende Komplementarmedizin (2006)"},{"key":"2837_CR44","first-page":"1293","volume":"24","author":"VF Semiglasov","year":"2004","unstructured":"Semiglasov VF, Stepula VV, Dudov A, Lehmacher W, Mengs U (2004) The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind multicentre clinical trial. Anticancer Res 24:1293\u20131302","journal-title":"Anticancer Res"},{"key":"2837_CR45","first-page":"1519","volume":"26","author":"VF Semiglasov","year":"2006","unstructured":"Semiglasov VF, Stepula VV, Dudov A, Schnitker J, Mengs U (2006) Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind multicentre clinical trial. Anticancer Res 26:1519\u20131529","journal-title":"Anticancer Res"},{"key":"2837_CR46","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1200\/JCO.2004.04.140","volume":"22","author":"HS Shaw","year":"2004","unstructured":"Shaw HS, Hobbs KB, Kroll DJ, Seewaldt VL (2004) Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy. J Clin Oncol 22:4432\u20134434. \n                    https:\/\/doi.org\/10.1200\/jco.2004.04.140","journal-title":"J Clin Oncol"},{"key":"2837_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/724258","author":"ML Steele","year":"2014","unstructured":"Steele ML, Axtner J, Happe A, Kroz M, Matthes H, Schad F (2014) Adverse drug reactions and expected effects to therapy with subcutaneous mistletoe extracts (Viscum album L.) in cancer patients. Evid Based Complement Altern Med eCAM 2014. \n                    https:\/\/doi.org\/10.1155\/2014\/724258","journal-title":"Evid Based Complement Altern Med eCAM 2014"},{"key":"2837_CR48","first-page":"23","volume":"37","author":"MK Steuer-Vogt","year":"2001","unstructured":"Steuer-Vogt MK et al (2001) The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial European. J Cancer 37:23\u201331","journal-title":"J Cancer"},{"key":"2837_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00106-005-1318-y","volume":"54","author":"MK Steuer-Vogt","year":"2006","unstructured":"Steuer-Vogt MK, Bonkowsky V, Scholz M, Fauser C, Licht K, Ambrosch P (2006) Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients. Hno 54:277\u2013286","journal-title":"Hno"},{"key":"2837_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/pbc.20513","volume":"46","author":"J Styczynski","year":"2006","unstructured":"Styczynski J, Wysocki M (2006) Alternative medicine remedies might stimulate viability of leukemic cells. Pediatr Blood Cancer 46:94\u201398. \n                    https:\/\/doi.org\/10.1002\/pbc.20513","journal-title":"Pediatr Blood Cancer"},{"key":"2837_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tox.2004.09.009","volume":"207","author":"A Thies","year":"2005","unstructured":"Thies A, Nugel D, Pfuller U, Moll I, Schumacher U (2005) Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro. Toxicology 207:105\u2013116. \n                    https:\/\/doi.org\/10.1016\/j.tox.2004.09.009","journal-title":"Toxicology"},{"issue":"1 Supplement 1","key":"2837_CR52","doi-asserted-by":"publisher","first-page":"S1295","DOI":"10.1016\/j.jtho.2016.11.1832","volume":"12","author":"A Thronicke","year":"2017","unstructured":"Thronicke A, Steele M, Grah C, Matthes B, Schad F (2017) Clinical safety of combinational therapy of immune checkpoint inhibitors and Viscum album L. in patients with advanced or metastasized cancer. Journal of Thorac Oncol 12(1 Supplement 1):S1295\u2013S1296","journal-title":"Journal of Thorac Oncol"},{"key":"2837_CR53","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/annonc\/mdt299","volume":"24","author":"A Trimborn","year":"2013","unstructured":"Trimborn A et al (2013) Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncology 24:2641\u20132645. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdt299","journal-title":"Ann Oncology"},{"key":"2837_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1055\/s-0030-1257628","volume":"43","author":"W Troger","year":"2011","unstructured":"Troger W (2011) Connection between quality of life and neutropenia in breast cancer patients who were solely treated with chemotherapy or additionally with mistletoe therapy: results of a randomized study. Deutsche Zeitschrift fur Onkologie [German] 43:58\u201367","journal-title":"Deutsche Zeitschrift fur Onkologie [German]"},{"key":"2837_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4137\/BCBCR.S2905","volume":"3","author":"W Troger","year":"2009","unstructured":"Troger W, Jezdic S, Zdrale Z, Tisma N, Hamre HJ, Matijasevic M (2009) Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone. Breast Cancer Basic Clin Res 3:35\u201345","journal-title":"Breast Cancer Basic Clin Res"},{"key":"2837_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4137\/BCBCR.S10558","volume":"6","author":"W Troger","year":"2012","unstructured":"Troger W, Zdrale Z, Stankovic N, Matijasevic M (2012) Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with Viscum album (L.) extract to chemotherapy alone. Breast Cancer Basic Clin Res 6:173\u2013180. \n                    https:\/\/doi.org\/10.4137\/BCBCR.S10558","journal-title":"Breast Cancer Basic Clin Res"},{"key":"2837_CR57","first-page":"3788","volume":"49","author":"W Troger","year":"2013","unstructured":"Troger W, Galun D, Reif M, Schumann A, Stankovic N, Milicevic M (2013) Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival European. J Cancer 49:3788\u20133797","journal-title":"J Cancer"},{"key":"2837_CR58","first-page":"493","volume":"111","author":"W Troger","year":"2014","unstructured":"Troger W, Galun D, Reif M, Schumann A, Stankovic N, Milicevic M (2014a) Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial. Deutsch Arzteblatt Int 111:493\u2013502","journal-title":"Deutsch Arzteblatt Int"},{"key":"2837_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/430518","author":"W Troger","year":"2014","unstructured":"Troger W, Zdrale Z, Tisma N, Matijasevic M (2014b) Additional therapy with a mistletoe product during adjuvant chemotherapy of breast cancer patients improves quality of life: an open randomized clinical pilot trial. Evid Based Complement Altern Med eCAM 2014. \n                    https:\/\/doi.org\/10.1155\/2014\/430518","journal-title":"Evid Based Complement Altern Med eCAM 2014"},{"key":"2837_CR60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/s-0042-113505","volume":"48","author":"W Troger","year":"2016","unstructured":"Troger W, Zdrale Z, Stankovic N (2016) Five-Year follow-up of patients with early stage breast cancer after a randomized study with Viscum album (L.) extract. [German]. Deutsche Zeitschrift fur Onkologie 48:105\u2013110","journal-title":"Deutsche Zeitschrift fur Onkologie"},{"key":"2837_CR61","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1016\/j.ejca.2013.06.043","volume":"49","author":"W Tr\u00f6ger","year":"2013","unstructured":"Tr\u00f6ger W, Galun D, Reif M, Schumann A, Stankovi N, Mili\u0107evi M (2013) Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer (Oxford Engl 1990) 49:3788\u20133797. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2013.06.043","journal-title":"Eur J Cancer (Oxford Engl 1990)"},{"key":"2837_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3238\/arztebl.2014.0493","volume":"111","author":"W Tr\u00f6ger","year":"2014","unstructured":"Tr\u00f6ger W, Galun D, Reif M, Schumann A, Stankovi N, Mili\u0107evi M (2014) Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial. Deutsch Arzteblatt Int 111:493\u2013502. \n                    https:\/\/doi.org\/10.3238\/arztebl.2014.0493","journal-title":"Deutsch Arzteblatt Int"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-018-02837-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-02837-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-02837-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T19:11:28Z","timestamp":1579720288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-018-02837-4"}},"subtitle":["Part\u00a01: survival and safety"],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2837"],"URL":"https:\/\/doi.org\/10.1007\/s00432-018-02837-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"26 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}